Who We Are

Prescription Justice, a 501c4 non-profit organization, brings together doctors, lawyers, public health and consumer advocates, and political activists dedicated to lowering drug prices in the United States. We advocate for all Americans, registered with all political parties, who are sick of high drug prices, and tired of greedy drug companies and the politicians they control. We also stand up for those who need to access more affordable imported medications now and stand against actions by the pharmaceutical industry that mislead and misinform the public.

Forty-five million Americans did not fill a prescription in 2016 due to cost. Millions often choose between food and medicine in the world’s richest country. Forgoing prescribed medication leads to sickness and death, and even larger healthcare costs from hospitalizations when patients stop taking their medications. Prescription Justice is dedicated to ending this crisis of high drug prices.

Executive Director

Jodi Dart

Ms. Dart has over thirteen years’ experience in non-profit association management. Most recently, she served as the Associate Executive Director for the Illinois Public Health Association (IPHA), an 8,000-member organization dedicated exclusively to protecting the public’s health. During her tenure, Ms. Dart was instrumental in developing IPHA’s social media platform, and its policy and governance process. She participated in numerous advocacy campaigns including the passage of the 2008 Smoke Free Illinois Act. In 2014, Ms. Dart was appointed as IPHA’s representative to the Illinois Terrorism Task Force (ITTF) which serves as an advisory body to Illinois Government providing recommendations and guidance on homeland security laws, policies, protocol, and procedures.

Ms. Dart has always had a passion for working to promote health and well-being for underserved populations. She began her career as a Health Educator for the Sangamon County Department of Public Health, where she worked to promote healthy behaviors and to prevent disease and illness through tailored community education and awareness programs. From there, Ms. Dart developed experience in grassroots advocacy and coalition building as a community organizer with the Illinois Coalition Against Tobacco (ICAT). While at ICAT, she worked with several health advocates to reduce tobacco use, especially among youth. Ms. Dart also managed the Washington, DC office of the Alliance for Nuclear Accountability (ANA), a network of local, regional, and national organizations representing the concerns of communities in the shadows of US nuclear weapons and radioactive waste dumps. During her tenure at ANA, she educated Members of Congress and Federal agency leaders on nuclear nonproliferation, nuclear waste, and reprocessing issues. She also worked against the Yucca Mountain Nuclear Waste Repository and the formation of the Global Nuclear Energy Partnership in the United States. Ms. Dart received her Master of Public Administration and Bachelor of Health Services Administration degrees from the University of Illinois. She resides in Springfield, Illinois with her husband Tom and daughter Gabriella.

Board of Directors

Stephen Barrett, MD Quackwatch

A retired psychiatrist who resides near Chapel Hill, North Carolina, Dr. Barrett has achieved national renown as an author, editor, and consumer advocate. In addition to heading Quackwatch, he is a Fellow of the Committee for Skeptical Inquiry. In 1984, he received an FDA Commissioner’s Special Citation Award for Public Service in fighting nutrition quackery. In 1986, he was awarded honorary membership in the American Dietetic Association. From 1987 through 1989, he taught health education at The Pennsylvania State University. He is listed in Marquis Who’s Who in America and received the 2001 Distinguished Service to Health Education Award from the American Association for Health Education.

Lindsay C. Brown  Software Developer

Lindsay Brown is a software developer and project manager who ran for the US House of Representatives in the 2018 Republican primary in New Jersey’s 7th district. Lindsay attended Skidmore College in Saratoga Springs, NY for her bachelors in Psychology. She built her career from part-time administrative roles and climbed the ranks to lead digital projects and software development efforts at Townsquare Media, the New York Post, and experiential media agency Impact XM. Lindsay is a full-stack web developer with strong familiarity of the MERN stack, SQL databases, and AWS architecture.In partnership with Severna Labs, Lindsay developed a sales tool aimed at FDA Outsourcing Facilities (503B) to aid in more efficient R&D decisions to get drugs on shortage back on the market through alternative sources. Politically, Lindsay is passionate about rebuilding the Republican party to reflect its historical values of diversity and inclusion, individual responsibility to uphold the public good, and civil liberties by championing causes that are important to all Americans, such as prescription drug policy reform, and electing new and diverse voices to positions of authority.

Tod Cooperman, MD President of ConsumerLab.com, CEO of PharmacyChecker.com

Dr. Tod Cooperman is a noted researcher, writer, and speaker on consumer healthcare issues. Dr. Cooperman is a graduate of the Boston University School of Medicine and received his Bachelor’s degree from Boston University with a major in Medical Sciences and a minor in Economics. Founded in 1999, ConsumerLab.com is the leading independent evaluator of dietary supplements (vitamin, mineral, herbal, and non-herbal) and nutrition products. In 2002, Dr. Cooperman started PharmacyChecker.com when he saw that increasing numbers of Americans were looking on the Internet to save money on prescription medication but did not have adequate information to protect their health. Dr. Cooperman also founded CareData Reports, Inc., an evaluator of consumer satisfaction with managed care (now a division of J.D. Power and Associates). Dr. Cooperman is also a blogger for the Huffington Post.

Doug Grover, Esq. Schlam Stone & Dolan LLP

Douglas Grover joined Schlam and Stone as a partner in 2014. Since leaving the Justice Department in 1990, he has focused on white-collar criminal matters and related civil litigation. He has represented and tried cases for businesses and individuals, including politicians, corporate officers, attorneys, doctors, accountants, securities analysts and traders, investment bankers, and government agents in all types of matters including campaign finance violations, government corruption (including bribery and foreign corrupt practices), environmental crimes, tax crimes, antitrust crimes, securities violations, insider trading, and all forms of fraud, including securities fraud, mail and telemarketing fraud, government procurement fraud, bank fraud, insurance fraud, and false statements to government officials and investigators. Click here for more on Mr. Grover’s experience.

Colleen Kenny LaRocque  Owner, Col Rock LLC

Colleen Kenny LaRocque is the owner of Col Rock LLC, an independent marketing and communications consultancy catering to corporations, nonprofits and individuals. Previously, Colleen spent 18 years in executive-level strategic communications roles at Fortune 100 companies. For over a decade, she was Vice President in charge of marketing and communications for CBS, America’s number one television network, and developed some of the world’s most well-known media brands. Colleen began her tenure at CBS as a financial speechwriter, responsible for earnings remarks, strategy presentations and Reg FD communications. Before joining CBS, Colleen led strategic planning and communications at the New York Life Insurance Company. Colleen has a Master’s degree in Mass Communication from UNC Chapel Hill and a Bachelor of Arts degree in English and Spanish from the University of Notre Dame where she graduated with honors in 1997. She has a lifelong interest in how ideas spread and drive change.

Gabriel Levitt President, PharmacyChecker.com

Gabe is a co-founder of PharmacyChecker.com, which evaluates online pharmacies, compares prescription drug prices, and helps Americans find the lowest cost medication at local pharmacies. He is also a public advocate for prescription drug affordability in America, Internet freedom, and the United Nations. He has testified before Congress on issues relating to access to affordable medicines and Internet freedom, published an op-ed in the New York Times about online pharmacies and personal drug importation, and is the proud author of a chapter in an anthology calling Hacking Politics about defeating the Stop Online Piracy Act (SOPA). Gabe is president emeritus of the United Nations Association Brooklyn Chapter and sits on the Brooklyn County Democratic Committee. He is the recipient of the United Nations Association Molly Bruce Advocacy Award. He received his Masters in International Relations from American University and a Bachelor’s degree in International Relations and Political Science from Roger Williams University.

What We Do

Prescription Justice empowers consumers to defend their personally imported prescription drug orders if the FDA refuses to allow their imports of lawfully manufactured, prescribed medication. If the FDA refuses a consumers’ imported medication to enter the country, the FDA must send them a letter explaining why and offer the opportunity to defend the prescription drug order before destroying it. Prescription Justice provides consumers with guidance to help them submit testimony letters to the FDA to get their medication shipments.

Prescription Justice advocates for regulatory and legislative reforms and common sense policies to lower domestic drug prices and expand access to lower cost medication from pharmacies in other countries.

Prescription Justice provides guidance on how Americans can best afford medication.

Policies we believe in

Allow the Federal Government to Negotiate Medicare Medication Prices

The Centers for Medicaid & Medicare should be allowed to negotiate medication prices with pharmaceutical companies to bring down taxpayer and consumer costs for Medicare enrollees. Currently, such negotiations are banned under the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA). Medicare’s Part D, a product of the MMA, was helpful in bringing prescription drug price relief to millions of seniors, but millions are still not taking medications due to cost or paying far more than they should have to on fixed incomes.

Letting Medicare negotiate will bring the power of 60 million people to the bargaining table to negotiate for lower drug prices, making sure all of our seniors can afford the medications they need.

Ban “Pay to Delay” to Improve Competition from Generic Medications

Pharmaceutical companies should be prevented from conspiring together to prevent lower cost generics from coming to market. “Pay to delay” deals involve payment by a brand-name company to a generic drug company to delay marketing a generic version that has obtained FDA approval to market in the United States. The Federal Trade Commission estimates that taxpayer drug costs were $3.5 billion higher in 2014 because of such deals. “Pay to delay” deals should be banned.

Legalize the Importation of Lower-Cost FDA-Approved Medications

The same medications sold in the U.S. are sometimes nine times less expensive in Canada and other countries. By definition, such medications are just as safe abroad as they are here. Prescription drug importation is already legal but, under the current rules, the pharmaceutical manufacturers control the distribution, which means they set higher prices in the U.S. than in other countries. In fact, according to the FDA, 40% percent of prescription medications we purchase in U.S. pharmacies are imported and 80% of their active pharmaceutical ingredients, the main ingredients found in medications, are imported.

Pharmacies and individuals in the U.S. are not allowed to import lower-cost, FDA-approved pharmaceuticals from Canada or other countries. Allowing them to do so would mean lower prices at U.S. pharmacies and for patients importing medication for personal use. We need laws that protect our medication supply, not import restrictions that profit pharmaceutical companies at the expense of American consumers.

Allow Individuals the Freedom to Make Informed Decisions Regarding the Importation of Affordable Medications for Their Own Care

Despite federal restrictions, about 20 million Americans have already imported medication for personal use each year because the cost of medication in the U.S. is too high.

The FDA should use enforcement discretion so as not to deprive patients access to prescribed, safe and effective medications. Millions of Americans import lower cost medication traveling to Canada and Mexico, ordering from international online pharmacies, or through U.S. based programs connecting them with international pharmacy options. They should not be stopped from doing so. In conjunction, the safest international pharmacy options should not be the target of enforcement actions, as they offer a lifeline of affordable medication.

Privacy Policy

This privacy policy discloses the privacy practices for this website. This privacy policy applies solely to information collected by this website.

Information Collection, Use, and Sharing

We are the sole owners of the information collected on this site. We only have access to/collect information that you voluntarily give us via email or other direct contact from you. We will not sell or rent this information to anyone. We will use your information to respond to you, regarding the reason you contacted us. We will not share your information with any third party outside of our organization, other than as necessary to fulfill your request. With your permission only, we may contact you via email in the future to tell you about new developments with our organization and its work, or changes to this privacy policy.


Our Privacy Policy may change from time to time and all updates will be posted on this page. If you feel that we are not abiding by this privacy policy, you should contact us immediately via email.